MGA’s Alex Brill Serves as a Panelist for “Biosimilars: Breaking Through the Barriers” Symposium
Skylar Jeremias | The Center for Biosimilars
Alex Brill was one of the panelists discussing his “commitment to expand biosimilar use in the United States and how physicians and government officials are looking to help.
[He] brought up that most legislation for biosimilars includes policies that focus on Medicare plans rather than employers and individual patients because “of the way Washington works…to encourage policymakers to pursue the policies that will drive biosimilar utilization by those types of things that will save money for the federal government.””
